Patents by Inventor Brian Arthur Michael Rudd

Brian Arthur Michael Rudd has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7592308
    Abstract: The present invention relates to methods and products for improved production of the lantibiotic mersacidin. There is provided a method of producing a mersacidin variant which comprises introducing into a cell which is a ?MrsA host cell an expression vector encoding said variant, and recovering said variant from the cell culture. Preferred variants include the novel variants of Table 1, e.g. mersacidin F3W, said mersacidin F3W optionally having a further one or more variations, e.g. mersacidin F3W G8A. Also provided is a Bacillus cell which is a SigH deficient strain of Bacillus sp. HIL Y-85,54728 (NCIMB Accession Number NCIMB 41211); this cell may also be used in the production of mersacidin and its variants. Further aspects of the invention include a DNA cassette which comprises a nucleotide sequence encoding the mersacidin mrsA propeptide, and a method to transform a Bacillus HIL host cell with plasmid, which method includes the step of electroporation.
    Type: Grant
    Filed: September 25, 2006
    Date of Patent: September 22, 2009
    Assignee: Novacta Biosystems Limited
    Inventors: Michael John Dawson, Jesus Cortes Bargallo, Antony Nicholas Appleyard, Brian Arthur Michael Rudd, Steven Boakes, Gabriele Bierbaum, Anja Hoffmann, Stephanie Schmitz
  • Patent number: 6177457
    Abstract: A process for preparing compounds of the formula: and intermediates for use in the process.
    Type: Grant
    Filed: December 8, 1998
    Date of Patent: January 23, 2001
    Assignee: Glaxo Wellcome S.A.
    Inventors: Jose Maria Bueno Calderon, Jesus Chicharro Gonzalo, Jose Fiandor Roman, Sophie Huss, Brian Arthur Michael Rudd